Literature DB >> 2760976

Adenovirus L1 52- and 55-kilodalton proteins are required for assembly of virions.

T B Hasson1, P D Soloway, D A Ornelles, W Doerfler, T Shenk.   

Abstract

A variant of adenovirus type 5 that contained a mutation within the L1 52- and 55-kilodalton (52/55K) protein-coding region was isolated. The mutant, termed ts369, produced L1 52/55K proteins with a two-amino-acid substitution and was temperature sensitive. Temperature-shift experiments indicated that the ts369 defect was late in the viral growth cycle. DNA replication and synthesis of late proteins occurred normally in ts369-infected cells at the nonpermissive temperature, but mature virions were not produced. Rather, capsidlike particles associated with the left-terminal region of the viral chromosome accumulated. These incomplete particles could not be chased into mature virions when the infected cells were shifted to the permissive temperature. However, previously synthesized proteins could be assembled into virions in the presence of a protein synthesis inhibitor upon shiftdown from the nonpermissive temperature, suggesting that the inactivation of the L1 52/55K proteins was reversible. These results indicate that the adenovirus L1 52/55K proteins play a role in the assembly of infectious virus particles.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760976      PMCID: PMC250951          DOI: 10.1128/JVI.63.9.3612-3621.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Genetic analysis of adenovirus type 2 III. Temperature sensitivity of processing viral proteins.

Authors:  J Weber
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

2.  Transcription unit mapping in adenovirus: regions of termination.

Authors:  S Iwamoto; F Eggerding; E Falck-Pederson; J E Darnell
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

3.  Characterization of temperature-sensitive mutants of adenovirus type 5--serology.

Authors:  W C Russel; C Newman; J F Williams
Journal:  J Gen Virol       Date:  1972-12       Impact factor: 3.891

4.  Synthesis and assembly of adenovirus 2. I. Polypeptide synthesis, assembly of capsomeres, and morphogenesis of the virion.

Authors:  M S Horwitz; M D Scharff; J V Maizel
Journal:  Virology       Date:  1969-12       Impact factor: 3.616

5.  Groups of adenovirus type 2 mRNA's derived from a large primary transcript: probable nuclear origin and possible common 3' ends.

Authors:  J R Nevins; J E Darnell
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

6.  Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing.

Authors:  J R Nevins; M C Wilson
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

7.  Regulation of simian virus 40 transcription: sensitive analysis of the RNA species present early in infections by virus or viral DNA.

Authors:  B A Parker; G R Stark
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

8.  Control of adenovirus early gene expression: a class of immediate early products.

Authors:  J B Lewis; M B Mathews
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

9.  Effects of novobiocin on adenovirus DNA synthesis and encapsidation.

Authors:  J C D'Halluin; M Milleville; P Boulanger
Journal:  Nucleic Acids Res       Date:  1980-04-11       Impact factor: 16.971

10.  Adenovirus DNA synthesis is coupled to virus assembly.

Authors:  J M Weber; C V Déry; M A Mirza; J Horvath
Journal:  Virology       Date:  1985-01-30       Impact factor: 3.616

View more
  47 in total

1.  Interaction of the adenovirus IVa2 protein with viral packaging sequences.

Authors:  W Zhang; M J Imperiale
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Minimal cis-acting elements required for adenovirus genome packaging.

Authors:  Philomena Ostapchuk; Patrick Hearing
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Adenovirus L1 52- and 55-kilodalton proteins are present within assembling virions and colocalize with nuclear structures distinct from replication centers.

Authors:  T B Hasson; D A Ornelles; T Shenk
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expression.

Authors:  Jackie L Stilwell; Douglas M McCarty; Atsuko Negishi; Richard Superfine; R Jude Samulski
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

5.  Analysis of the interaction of the adenovirus L1 52/55-kilodalton and IVa2 proteins with the packaging sequence in vivo and in vitro.

Authors:  Pilar Perez-Romero; Ryan E Tyler; Johanna R Abend; Monica Dus; Michael J Imperiale
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  The L4 22-kilodalton protein plays a role in packaging of the adenovirus genome.

Authors:  Philomena Ostapchuk; Mary E Anderson; Sharanya Chandrasekhar; Patrick Hearing
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Dependence of the encapsidation function of the adenovirus L1 52/55-kilodalton protein on its ability to bind the packaging sequence.

Authors:  Pilar Perez-Romero; Kurt E Gustin; Michael J Imperiale
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  The adenovirus L4 33-kilodalton protein binds to intragenic sequences of the major late promoter required for late phase-specific stimulation of transcription.

Authors:  Humayra Ali; Gary LeRoy; Gemma Bridge; S J Flint
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

9.  Role for the L1-52/55K protein in the serotype specificity of adenovirus DNA packaging.

Authors:  Beverly P Wohl; Patrick Hearing
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

10.  Presence of the adenovirus IVa2 protein at a single vertex of the mature virion.

Authors:  Joan B Christensen; Serena A Byrd; Angela K Walker; John R Strahler; Philip C Andrews; Michael J Imperiale
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.